News from the healthcare data industry
Treatment patterns are generally similar for patients with metastatic colorectal cancer (mCRC), whether or not they have KRAS p.G12C mutations, according to a real-world study published in The Oncologist. The data also showed...
ALEXANDRIA, Va. and PALO ALTO, Calif., May 3, 2022 /PRNewswire/ — ASCO’s CancerLinQ® and Atropos Health announced today a new collaboration that will provide oncology clinicians with the latest real-world evidence available to help inform personalized...
May 2, 2022C.K. Wang, MD By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the...
PrecisionOCR quickly analyzes patient records to allow xCures to extract medical data and match patients with potential treatments INDIANAPOLIS , April 28, 2022 /PRNewswire/ — LifeOmic, a software company that leverages the cloud, machine...
Sucharita Mistry, PhD Real-world data confirm that there is no standard approach for treating patients with triple-class-exposed relapsed/refractory multiple myeloma (RRMM), and these patients continue to have poor outcomes. Researchers...
People with different ancestries inherit different risks and encounter different environmental exposures resulting in different somatic profiles. Research Presented at the American Association for Cancer Research (AACR) Annual Meeting, held...
April 13, 2022 09:50 AM Eastern Daylight Time DALLAS–(BUSINESS WIRE)–Texas Oncology announced today that it has entered into an agreement with Foundation Medicine, a pioneer in molecular profiling for cancer,...
April 13, 2022 Michael Vasconcelles, MD, Brad Jordan, PhD Evidence-Based Oncology, April 2022, Volume 28, Issue 3Pages: SP142-SP143 Recent steps by FDA to promote the use of real-world evidence are to be commended, but...
Underrepresentation of racial minorities in clinical trials for cancer and other diseases isn’t new; there has been a significant dearth in the representation of minorities in oncology trials for years....
April 08, 2022 04:01 PM Eastern Daylight Time OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today shared details of its participation at the upcoming American Association for Cancer...